Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

D-Dimer

Coagulation

DDFibrin D-dimer

Review status

Currently under review

Pending specialist review and validation.

What it shows

D-Dimer is a small protein fragment released when your body breaks down a blood clot. The test measures how much of this fragment is present in your blood, which reflects ongoing clot formation and breakdown.

It is commonly used in the evaluation of symptoms that may be caused by a clot in a vein of the leg or lungs, and it can support the assessment of a widespread clotting disorder. Results are influenced by the type of assay, which may report in fibrin equivalent units or in dimer units.

Why it matters

Clinicians order this test when you have symptoms that could be due to a blood clot, together with a clinical assessment of your overall likelihood. When that likelihood is low or moderate, a result within the expected range can help rule out a new clot without additional imaging.

An elevated result is not specific to a single condition. Many situations can raise D-Dimer, including recent surgery or trauma, infection, inflammation, liver disease, pregnancy, and some cancers. The test can also aid in evaluating and monitoring a serious condition where clotting and bleeding happen at the same time.

Understanding your results

Your result is interpreted alongside your symptoms, exam, and clinical risk. A value within the expected range generally makes an acute clot unlikely, while a higher value may prompt imaging studies or closer follow up. The exact next step depends on your overall picture, not the lab number alone.

Age, pregnancy, chronic illness, and recent procedures can influence results and how they are used in decision making. Some care teams apply age-adjusted decision thresholds to reduce false alarms. If you are taking blood thinners, levels can be lower than otherwise expected. Ask your clinician what your result means for you and whether further testing or observation is advised.

Reference ranges

00.55 ug/mLFEU
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact D-Dimer

  • Recent surgery or injury

    Tissue damage from operations or trauma can increase D-Dimer for days, even without a new clot, which may lead to false positive results.

  • Inflammation and infection

    Conditions such as pneumonia, autoimmune disease, or widespread inflammation stimulate clot turnover and can raise D-Dimer independent of a clot.

  • Anticoagulant and thrombolytic drugs

    Blood thinners can lower D-Dimer by reducing clot formation, while clot-busting medicines can transiently increase it as clots are broken down.

  • Pregnancy and postpartum

    Normal changes in pregnancy and the period after delivery raise D-Dimer, so interpretation requires clinical context and often different decision strategies.

  • Age and chronic disease

    Older age, cancer, liver disease, and kidney problems can shift baseline levels, which may reduce test specificity in those settings.

  • Sample collection and handling

    Improper tube filling, delays in processing, or hemolysis can affect results. Providing a properly collected sample helps ensure accuracy.

2026

References

  1. McGill University Health Centre. (2015, July 09). D-Dimer (Task CD 316320). Laboratory reference ranges.
  2. McGill University Health Centre. (2020, July 15). D-Dimer (Task CD 316320). Laboratory reference ranges.
  3. Lim, W., Le Gal, G., Bates, S. M., Righini, M., Haramati, L. B., Lang, E., Kline, J. A., Chasteen, S., Snyder, M., Patel, P., Bhatt, M., Patel, P., & Kearon, C. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Diagnosis of venous thromboembolism. Blood Advances, 2(22), 3226–3256. External link
  4. Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G. J., Harjola, V. P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., Kucher, N., Lang, I. M., Lankeit, M., Lorusso, R., Mazzolai, L., Meneveau, N., Ni Ainle, F., Prandoni, P., Pruszczyk, P., Zotz, R. B., & the ESC Scientific Document Group. (2019). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. European Heart Journal, 41(4), 543–603. External link